AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 57 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,195 | -1.7% | 65,083 | -21.1% | 0.00% | – |
| Q2 2023 | $75,463 | +63.3% | 82,473 | 0.0% | 0.00% | – |
| Q1 2023 | $46,218 | -2.9% | 82,473 | 0.0% | 0.00% | – |
| Q4 2022 | $47,587 | +83.0% | 82,473 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | -10.3% | 82,473 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | -67.0% | 82,473 | -32.6% | 0.00% | – |
| Q1 2022 | $88,000 | -68.0% | 122,395 | +0.6% | 0.00% | – |
| Q4 2021 | $275,000 | -21.7% | 121,698 | -0.2% | 0.00% | – |
| Q3 2021 | $351,000 | -65.1% | 122,000 | +41.0% | 0.00% | – |
| Q4 2014 | $1,007,000 | -89.2% | 86,500 | -79.5% | 0.00% | -100.0% |
| Q3 2014 | $9,328,000 | -34.2% | 421,500 | -17.4% | 0.00% | -33.3% |
| Q2 2014 | $14,184,000 | – | 510,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |